SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-08-008552
Filing Date
2008-02-13
Accepted
2008-02-13 16:50:28
Documents
1
Group Members
CITADEL ADVISORS LLCCITADEL DERIVATIVES GROUP LLCCITADEL DERIVATIVES TRADING LTD.CITADEL EQUITY FUND LTD.CITADEL HOLDINGS I LPCITADEL HOLDINGS II LPCITADEL INVESTMENT GROUP II, L.L.C.CITADEL LIMITED PARTNERSHIPKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 v102561_sc-13ga.htm SC 13G/A 359495
  Complete submission text file 0001144204-08-008552.txt   361934
Mailing Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Subject) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-38286 | Film No.: 08605754
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address CITADEL INVESTMENT GROUP LLC 131 S DEARBORN STREET 32ND FL CHICAGO IL 60603
Business Address CITADEL INVESTMENT GROUP LLC 131 S DEARBORN STREET 32ND FL CHICAGO IL 60603 3123952100
CITADEL INVESTMENT GROUP LLC (Filed by) CIK: 0001255158 (see all company filings)

IRS No.: 364108019 | State of Incorp.: DE
Type: SC 13G/A